Clinical Trials

Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1
  • Intervention Type: Biological
  • Participants: 44
  • Start Date: May 1, 2021
Constitutive IL7 (C7R) Modified EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1
  • Intervention Type: Biological
  • Participants: 10
  • Start Date: March 2021
Preemptive Infusion of Donor Lymphocytes Depleted of TCR (Alpha-beta) + T Cells and CD19+ B Cells Following Allogeneic Stem Cell Transplantation
Search for trials
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 12
  • Start Date: February 20, 2021
Pilot Trial of Leflunomide in Patients With CD30+ Lymphoproliferative Disorders
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug, Procedure, Radiation
  • Participants: 56
  • Start Date: September 22, 2020
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immunodeficiency Diseases
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Diagnostic Test, Drug
  • Participants: 62
  • Start Date: September 2, 2020
Phase II Study of Rituximab and Acalabrutinib in Newly Diagnosed B Cell Post Transplant Lymphoproliferative Disorder (PTLD)
Clinical Trial
  • Status: Recruiting
  • Phase: Early Phase 1
  • Intervention Type: Drug
  • Participants: 50
  • Start Date: August 2020
Value of Chemokine Receptor CXCR4-targeting Molecular Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1/Phase 2
  • Intervention Type: Biological
  • Participants: 10
  • Start Date: July 7, 2020
Ex-vivo Delivery of Rituximab to Prevent Post-transplant Lymphoproliferative Disease in Epstein-Barr Virus Mismatch Lung Transplant Recipients: A Pilot Trial
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1/Phase 2
  • Intervention Type: Biological
  • Participants: 108
  • Start Date: May 12, 2020
A Phase I/II Study of Human Placental Hematopoietic Stem Cell Derived Natural Killer Cells (CYNK 001) in Multiple Myeloma Patients Following Autologous Stem Cell Transplant in the Front-line Setting.
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Diagnostic Test
  • Participants: 500
  • Start Date: January 3, 2020
EVITA Study - Epstein-Barr Virus Infection moniToring in renAl Transplant Recipients - Early Identification of Increased Risk of Infection and Cancer for Individualised Immunosuppression.
Clinical Trial
  • Status: Recruiting
  • Participants: 40
  • Start Date: August 25, 2019
Lymphoproliferative Disorders After Diagnosis of Childhood Acute Lymphoblastic Leukemia/Lymphoma
Clinical Trial
  • Status: Recruiting
  • Participants: 1650
  • Start Date: July 3, 2019
Oxford Pre-cancerous Lymphoproliferative Disorders: Analysis and Interception Study
Clinical Trial
  • Status: Recruiting
  • Phase: Early Phase 1
  • Intervention Type: Biological, Procedure
  • Participants: 18
  • Start Date: May 31, 2019
Immunotherapy With Tacrolimus Resistant EBV CTL for Lymphoproliferative Disease After Solid Organ Transplant
Showing 1-12 of 60